- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/20 - Spiro-condensed systems
Patent holdings for IPC class C07D 513/20
Total number of patents in this class: 110
10-year publication summary
|
9
|
3
|
1
|
6
|
10
|
7
|
17
|
7
|
8
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amgen Inc. | 4357 |
13 |
| Janssen Pharmaceutica N.V. | 3231 |
9 |
| Gilead Sciences, Inc. | 2189 |
7 |
| Novartis AG | 10327 |
5 |
| Erasca, Inc. | 92 |
5 |
| Merck Sharp & Dohme LLC | 3729 |
4 |
| The Regents of the University of Michigan | 4918 |
3 |
| Biogen MA Inc. | 933 |
3 |
| The Broad Institute, Inc. | 1937 |
3 |
| Chugai Seiyaku Kabushiki Kaisha | 1394 |
3 |
| Jazz Pharmaceuticals Ireland Limited | 166 |
3 |
| Aranda Pharma Ltd | 5 |
2 |
| Janssen Sciences Ireland UC | 167 |
2 |
| Ascentage Pharma (Suzhou) Co., Ltd. | 220 |
2 |
| Ascentage Pharma Group Corp Limited | 143 |
2 |
| Avelos Therapeutics, Inc. | 16 |
2 |
| Fundação GIMM - Gulbenkian Institute for Molecular Medicine | 21 |
2 |
| LG Chem, Ltd. | 17846 |
1 |
| Genentech, Inc. | 4076 |
1 |
| Pfizer Inc. | 3367 |
1 |
| Other owners | 37 |